Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03644524 · ClinicalTrials.gov registry record · NA

Heat Therapy and Cardiometabolic Health in Obese Women

A NA study, sponsored by University of Oregon.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03644524 is a NA study that has completed, run by University of Oregon. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03644524, a NA study, has completed, sponsored by University of Oregon.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Traditional medical treatments are often based on research done exclusively in males, and recent research efforts in the physiology community have highlighted critical sex differences in disease presentation and progression. For example, the relative risk of fatal heart disease is 50% greater in obese, diabetic women as compared to their male counterparts, and women appear to respond differently to lifestyle interventions such as exercise compared with men. Chronic passive heat exposure (hot tub use) provides alternative or supplemental therapeutic potential for improving cardiovascular and metabolic health in obese women. In addition, passive heat exposure may offer specific cellular protection from stresses like a lack of blood flow (ischemia), which is the primary cause of fatal coronary heart disease. This study is investigating the possible cardiovascular and metabolic health benefits of chronic passive heat exposure, and whether regular hot tub use (3-4 days per week for 8-10 weeks) may reduce obese womens' cardiometabolic risk. The investigators are examining cardiovascular health through blood pressure, blood vessel stiffness, sympathetic ('fight or flight') activity, and responsiveness to stresses like increased or decreased blood flow. The investigators are also examining metabolic health through an oral glucose tolerance test and a subcutaneous fat biopsy. The goal of this research is to develop a therapy targeted toward the specific health needs and complications of obese women, in an effort to improve cardiovascular and metabolic health and provide therapeutic alternatives in this high-risk population.

Interventions

  • BEHAVIORAL Heat therapy

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2015-09-08
Est. Completion 2018-07-01
Phase NA

Sponsor

University of Oregon

63 total trials

What the Registry Record Tells You About NCT03644524

The ClinicalTrials.gov registry entry for NCT03644524 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oregon, which has 63 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Heat therapy is the first listed.

NCT03644524 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03644524 about?

NCT03644524 is a clinical study titled "Heat Therapy and Cardiometabolic Health in Obese Women". Traditional medical treatments are often based on research done exclusively in males, and recent research efforts in the physiology community have highlighted critical sex differences in disease presentation and progression. For example, the relative risk of fatal heart disease is 50% greater in obe...

What is the current status of trial NCT03644524?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-09-08. Estimated completion is 2018-07-01.

What interventions are being tested in trial NCT03644524?

The interventions under investigation include: Heat therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03644524?

This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.